EU antitrust regulators scrutinize J&J, Novartis units

The European Commission has taken formal steps to advance an antitrust investigation involving subsidiaries of Johnson & Johnson and Novartis concerning the painkiller fentanyl. "If our preliminary conclusions are confirmed, the Dutch subsidiaries of Johnson & Johnson and Novartis entered into a so-called 'co-promotion' agreement to avoid competing against each other, depriving users of fentanyl in the Netherlands from access to a cheaper pain killer," an EC official said in a statement. Both companies said they acted properly, and they will have the opportunity to examine the EC's files, make comments and seek a hearing.

View Full Article in:

PharmExec.com · New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ